ArticleBMJ open2025

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial.

Johannes M Schwenke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.